Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Protein-Binding Behavior of Platinum Anticancer Drugs in Blood Revealed by Mass Spectrometry
Jingchen Wang, Jianmei Tao, Shuailong Jia, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 104-104
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer
Reyhaneh Farghadani, Rakesh Naidu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2144-2144
Open Access | Times Cited: 82
A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer
Manijeh Goldberg, Aaron Manzi, Amritpreet Birdi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
Metallodrug binding to serum albumin: Lessons from biophysical and structural studies
Antonello Merlino
Coordination Chemistry Reviews (2023) Vol. 480, pp. 215026-215026
Open Access | Times Cited: 36
Overview of therapeutic drug monitoring and clinical practice
Zijun Fang, He Zhang, Jiuchuan Guo, et al.
Talanta (2023) Vol. 266, pp. 124996-124996
Closed Access | Times Cited: 35
High cancer selectivity and improving drug release from mesoporous silica nanoparticles in the presence of human serum albumin in cisplatin, carboplatin, oxaliplatin, and oxalipalladium treatment
Mahboube Eslami Moghadam, Maryam Sadeghi, Hassan Mansouri‐Torshizi, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 187, pp. 106477-106477
Open Access | Times Cited: 28
Selective fluorescence turn-on detection of combination cisplatin–etoposide chemotherapy based on N-CDs/GSH-CuNCs nanoprobe
Khalid Alhazzani, Ahmed Z. Alanazi, Aya M. Mostafa, et al.
RSC Advances (2024) Vol. 14, Iss. 4, pp. 2380-2390
Open Access | Times Cited: 15
A review on the recent advances of interaction studies of anticancer metal-based drugs with therapeutic targets, DNA and RNAs
Huzaifa Yasir Khan, Mohammad Fawad Ansari, Sartaj Tabassum, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104055-104055
Closed Access | Times Cited: 9
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2119-2119
Open Access | Times Cited: 17
Recent Advances in Metalloproteomics
James P. C. Coverdale, Sirilata Polepalli, Marco Aurélio Zezzi Arruda, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 104-104
Open Access | Times Cited: 6
Photosubstitution and photoreduction of a diazido platinum(iv) anticancer complex
Huayun Shi, Christian Ward-Deitrich, Fortuna Ponte, et al.
Dalton Transactions (2024) Vol. 53, Iss. 31, pp. 13044-13054
Open Access | Times Cited: 5
Selenol (-SeH) as a target for mercury and gold in biological systems: Contributions of mass spectrometry and atomic spectroscopy
Mikel Bernabeu de Maria, Jérémy Lamarche, Luisa Ronga, et al.
Coordination Chemistry Reviews (2022) Vol. 474, pp. 214836-214836
Closed Access | Times Cited: 18
Atomic Spectrometry Update: review of advances in elemental speciation
Robert Clough, Chris F. Harrington, Steve J. Hill, et al.
Journal of Analytical Atomic Spectrometry (2022) Vol. 37, Iss. 7, pp. 1387-1430
Open Access | Times Cited: 15
A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma
Jorge Luis JImenez-Macias, Y.-C. Lee, Eric J. Miller, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 623-636
Open Access | Times Cited: 15
Transcranial focused ultrasound-mediated unbinding of phenytoin from plasma proteins for suppression of chronic temporal lobe epilepsy in a rodent model
Evgenii Kim, Hyun‐Chul Kim, Jared Van Reet, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Trace cisplatin and carboplatin removal by 3-mercaptopropionic acid and l-cysteine functionalized sponges: Adsorption behaviour and mechanism
Dong Han, Montserrat López‐Mesas, Roberto Boada, et al.
Chemical Engineering Journal (2023) Vol. 472, pp. 144894-144894
Open Access | Times Cited: 6
Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity
Angelico D. Aputen, Maria George Elias, Jayne Gilbert, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2181-2181
Open Access | Times Cited: 2
Mass spectrometry insights into interactions of selenoprotein P with auranofin and cisplatin
Jani Lamarche, Katarzyna Bierła, Laurent Ouerdane, et al.
Journal of Analytical Atomic Spectrometry (2022) Vol. 37, Iss. 5, pp. 1010-1022
Closed Access | Times Cited: 10
Cisplatin conjugation with an exopolysaccharide extracted from Lactobacillus gasseri potentiates its efficacy and attenuates its toxicity
Nisha Sharma, Shaheen Wasil Kabeer, Inder Pal Singh, et al.
International Journal of Biological Macromolecules (2022) Vol. 225, pp. 227-240
Closed Access | Times Cited: 10
Systematic Identification of Proteins Binding with Cisplatin in Blood by Affinity Chromatography and a Four-Dimensional Proteomic Method
Jianmei Tao, Shuailong Jia, Meiqin Wang, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 9, pp. 4553-4565
Closed Access | Times Cited: 10
Improving In Vivo Tumor Accumulation and Efficacy of Platinum Antitumor Agents by Electronic Tuning of the Kinetic Lability
M Manikandan, Sushanta Chhatar, Shubhankar Gadre, et al.
Chemistry - A European Journal (2023) Vol. 30, Iss. 4
Closed Access | Times Cited: 3
Speciation Analysis Highlights the Interactions of Auranofin with the Cytoskeleton Proteins of Lung Cancer Cells
Monika Kupiec, Agnieszka Tomaszewska, Wioletta Jakubczak, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1285-1285
Open Access | Times Cited: 5
Surrounded by ligands: the reactivity of cisplatin in cell culture medium
Matthew D. Hall
JBIC Journal of Biological Inorganic Chemistry (2022) Vol. 27, Iss. 8, pp. 691-694
Closed Access | Times Cited: 5
Interspecies and in vitro‐in vivo scaling for quantitative modeling of whole‐body drug pharmacokinetics in patients: Application to the anticancer drug oxaliplatin
Simona Catozzi, Roger J. Hill, Xiaomei Li, et al.
CPT Pharmacometrics & Systems Pharmacology (2022) Vol. 12, Iss. 2, pp. 221-235
Open Access | Times Cited: 5
In vivo behavior of [64Cu]NOTA-terpyridine platinum, a novel chemo-radio-theranostic agent for imaging, and therapy of colorectal cancer
Meysam Khosravifarsani, Samia Aı̈t-Mohand, Benoît Paquette, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Current and emerging mass spectrometry methods for the preclinical development of metal-based drugs: a critical appraisal
Maciej Jarosz, Bernhard K. Keppler, Andrei R. Timerbaev
Analytical and Bioanalytical Chemistry (2021) Vol. 414, Iss. 1, pp. 95-102
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top